Sanofi-aventis: (NYSE: SNY)

$54.50

0.29 (0.54%)

Volume 1,645,550

May 17 04:00 PM ET

Zacks Rank: 4-Sell

 
 
 
#4
 

Income Statements

Get Income Statements for:

Annual Income Statement

Fiscal Year End for SANOFI-AVENTIS falls in the month of December .

All items in Millions except EPS data.

12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Sales 46,244 48,829 42,542 42,883 42,390
Cost Of Goods 14,299 15,184 11,576 10,989 10,793
Gross Profit 31,945 33,644 30,966 31,893 31,597
Selling & Adminstrative & Depr. & Amort Expenses 22,069 23,200 20,580 20,990 22,917
Income After Depreciation & Amortization 9,876 10,445 10,386 10,903 8,680
Non-Operating Income -2,318 -3,036 -2,951 -2,443 -2,558
Interest Expense 0 0 0 0 0
Pretax Income 7,558 7,408 7,435 8,460 6,122
Income Taxes 1,458 634 1,649 1,902 1,003
Minority Interest 0 0 0 0 649
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 505 1,490 1,811 1,379 1,194
Income From Cont. Operations 6,605 8,265 7,597 7,937 5,665
Extras & Discontinued Operations 0 0 0 0 0
Net Income 6,605 8,265 7,597 7,937 5,665
Depreciation Footnote 12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Income Before Depreciation & Amortization 16,187 18,179 17,197 17,891 17,484
Depreciation & Amortization (Cash Flow) 6,311 7,734 6,811 6,988 8,804
Income After Depreciation & Amortization 9,876 10,445 10,386 10,903 8,680
Earnings Per Share Data 12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Average Shares 2,639.00 2,643.40 2,610.60 2,611.80 2,610.52
Diluted EPS Before Non-Recurring Items 4.13 4.36 4.81 4.45 3.98
Diluted Net EPS 2.55 2.83 2.85 2.77 2.17

Quarterly Income Statement

Fiscal year end for SANOFI-AVENTIS falls in the month of December .

All items in Millions except EPS data.

03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Sales 10,603.39 11,551.62 11,758.41 10,762.86 11,247.29
Cost Of Goods 3,353.76 3,733.66 3,609.03 3,512.17 3,443.99
Gross Profit 7,291.36 7,515.06 7,953.89 8,204.07 8,272.41
SG&A, R&D, and Dept/Amort Expenses 5,428.88 5,929.61 5,106.95 5,811.20 5,221.70
Income After SG&A, R&D, and Dept/Amort Expenses 1,862.48 1,585.45 2,846.94 2,392.87 3,050.71
Non-Operating Income 120.20 -1,241.67 -269.05 -492.19 -314.64
Interest Expense 207.38 0.00 NA 0.00 NA
Pretax Income 1,775.28 343.81 2,577.88 1,900.66 2,736.05
Income Taxes 410.79 -249.30 578.14 479.34 650.25
Minority Interest NA -64.25 NA 64.25 NA
Investment Gains/Losses NA 0.00 NA 0.00 NA
Other Income/Charges 14.52 -19.97 -1.25 147.78 378.87
Income From Cont. Operations 1,320.98 555.50 2,027.81 1,420.89 2,414.38
Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Net Income 1,320.98 555.50 2,027.81 1,420.89 2,414.38
Earnings Per Share Data 03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Average Shares 2,642.11 2,641.80 2,642.37 2,634.80 2,642.40
Diluted EPS Before Non-Recurring Items 0.80 0.78 1.10 0.90 1.22
Diluted Net EPS 0.50 0.21 0.77 0.54 0.91
 

SNY Chart by YCharts

Quick Links

Services

My Account

Resources

Client Support

Follow Us

Facebook

Twitter

Linkedin

RSS

You Tube

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.

Copyright 2013 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.